WO2007002739A3 - Chromium-amino acid complexes in the treatment of diabetes and other diseases - Google Patents
Chromium-amino acid complexes in the treatment of diabetes and other diseases Download PDFInfo
- Publication number
- WO2007002739A3 WO2007002739A3 PCT/US2006/025131 US2006025131W WO2007002739A3 WO 2007002739 A3 WO2007002739 A3 WO 2007002739A3 US 2006025131 W US2006025131 W US 2006025131W WO 2007002739 A3 WO2007002739 A3 WO 2007002739A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chromium
- diabetes
- diseases
- treatment
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/76—Metal complexes of amino carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compositions comprising chromium (III) 1:3 complexes comprising amino acids and methods of use thereof are provided.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69454305P | 2005-06-28 | 2005-06-28 | |
| US60/694,543 | 2005-06-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007002739A2 WO2007002739A2 (en) | 2007-01-04 |
| WO2007002739A3 true WO2007002739A3 (en) | 2007-03-15 |
Family
ID=37596010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/025131 WO2007002739A2 (en) | 2005-06-28 | 2006-06-28 | Chromium-amino acid complexes in the treatment of diabetes and other diseases |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US7271278B2 (en) |
| WO (1) | WO2007002739A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008013190A (en) * | 2006-04-12 | 2009-02-10 | Interhealth Nutraceuticals Inc | Trivalent chromium compounds, compositions and methods of use. |
| US8637096B2 (en) | 2009-12-04 | 2014-01-28 | Curtis C. Stojan | Compositions and method for enhancing insulin activity |
| CN102659844A (en) * | 2012-05-21 | 2012-09-12 | 山西大学 | Cr (III) chelate, and preparation method and application thereof |
| CN103224532A (en) * | 2013-04-17 | 2013-07-31 | 山西大学 | Cr(III) compound, and preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040253327A1 (en) * | 2003-06-12 | 2004-12-16 | Niazi Sarfaraz K. | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides, and sugar and preventing or treating cardiovascular diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5266560A (en) * | 1988-06-03 | 1993-11-30 | Thomas Research Corporation | Pharmaceutical insulin-potentiating CR(III) complexes with GTF-like activity |
| US6689383B1 (en) * | 1999-10-08 | 2004-02-10 | The United States Of America As Represented By The Secretary Of Agriculture | Chromium-histidine complexes as nutrient supplements |
| US7022351B2 (en) * | 2003-01-14 | 2006-04-04 | Zinpro Corporation | Composition for supplementing animals with solutions of essential metal amino acid complexes |
-
2006
- 2006-06-28 US US11/476,287 patent/US7271278B2/en not_active Expired - Fee Related
- 2006-06-28 WO PCT/US2006/025131 patent/WO2007002739A2/en active Application Filing
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040253327A1 (en) * | 2003-06-12 | 2004-12-16 | Niazi Sarfaraz K. | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides, and sugar and preventing or treating cardiovascular diseases |
Non-Patent Citations (2)
| Title |
|---|
| OHH ET AL.: "Effect of different forms of chromium supplement on serum glucose, insulin, and lipids in rats", JOURNAL OF FOOD SCIENCE AND NUTRITION, vol. 9, no. 4, 2004, pages 342-5, XP008078275 * |
| YANG X. ET AL.: "A newly synthetic chromium complex-chromium(phenylalanine)3 improves insulin responsiveness and reduces whole body glucose tolerance", FEBS LETTERS, vol. 579, no. 6, 2005, pages 1458 - 1464, XP004853057 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US7271278B2 (en) | 2007-09-18 |
| WO2007002739A2 (en) | 2007-01-04 |
| US20070015826A1 (en) | 2007-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006111524A3 (en) | Il-21 variants | |
| WO2006035237A3 (en) | Methods and compositions relating to alzheimer's disease | |
| EP1767544A3 (en) | Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 | |
| WO2007022518A8 (en) | New uses of glucoregulatory proteins | |
| WO2006099610A3 (en) | Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy | |
| WO2007061939A3 (en) | Metabolite derivatives of the hdac inhibitor fk228 | |
| WO2006093348A3 (en) | Method and composition for treating peripheral vascular diseases | |
| WO2006068729A3 (en) | Methods and compositions for enhancing iron absorption | |
| EP1731604A4 (en) | Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid | |
| HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| WO2009009562A3 (en) | Glp-1-fc fusion protein formulation | |
| WO2006105112A3 (en) | Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people | |
| MY153198A (en) | Inhibitors of protein aggregation | |
| WO2006034373A3 (en) | Variants and chemically-modified variants of phenylalanine ammonia-lyase | |
| WO2007014943A3 (en) | Therapy for neurological diseases | |
| EP1614675A3 (en) | Amino acids with affinity for the alpha-2-delta protein | |
| WO2006078576A3 (en) | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
| WO2004047792A3 (en) | Liposomal glucocorticoids | |
| WO2008049920A3 (en) | Il-21 variants | |
| WO2008033987A3 (en) | Compositions and methods to prevent cancer with cupredoxins | |
| WO2003066597A3 (en) | Guanidino compounds | |
| ZA200702318B (en) | Nanobodies against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neual diseases such as alzheimer's disease | |
| WO2006119983A3 (en) | Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy | |
| WO2007002739A3 (en) | Chromium-amino acid complexes in the treatment of diabetes and other diseases | |
| WO2005079396A3 (en) | O,o'-amidomalonate and n,o-amidomalonate platinum complexes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06774173 Country of ref document: EP Kind code of ref document: A2 |